Connection lost
Server error
United States v. Articles of Drug Case Brief
Why Top Law Students (And Those Aspiring to Be) Use LSD+ Briefs
Let's be real, law school is a marathon. Our exclusive Flash-to-Full case system is designed by Harvard Law School and MIT grads to match your pace: Quick summaries when you're slammed, detailed analysis when you need to go deep. Only LSD+ offers this kind of flexibility to genuinely fit your study flow.
Adaptive Case Views
Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.
Exam-Ready IRAC Format
We deliver the precise structure professors look for in exam answers.
Complex Cases, Clarified
We break down dense legal reasoning into something digestible, helping you grasp core concepts.
Case Brief Summary & Legal Analysis
tl;dr: A drug distributor challenged an FDA seizure of its products as misbranded “imitation” drugs. The court upheld the seizure but narrowed the definition of “imitation” and found the resulting injunction was justified but procedurally defective for lacking specificity.
Legal Significance: This case defines an “imitation” drug under the Food, Drug, and Cosmetic Act (FDCA) as one physically resembling a genuine drug, rejecting a broader “similar in concept” test, and reinforces the specificity requirements for injunctions in agency enforcement actions.
United States v. Articles of Drug Law School Study Guide
Use this case brief structure for your own legal analysis. Focus on the IRAC methodology to excel in law school exams and cold calls.
Case Facts & Court Holding
Key Facts & Case Background
Midwest Pharmaceuticals, Inc. distributed over-the-counter drug products containing caffeine and other legal stimulants. The products were intentionally designed to resemble controlled substances in size, shape, and color. Midwest marketed these products in bulk using street names like “357 Magnum” in subculture magazines, without listing ingredients or indications. The Food and Drug Administration (FDA) seized approximately 15 tons of Midwest’s drugs, alleging they were “misbranded” because they were “imitations” of other drugs in violation of 21 U.S.C. § 352(i)(2). The government presented evidence that Midwest’s principals knew and encouraged customers to “pass off” the products as illegal controlled substances for a significant profit. The district court condemned the drugs and issued a broad injunction preventing Midwest from marketing the seized products or similar ones using techniques that advertise based on appearance. Midwest appealed, arguing the term “imitation” was unconstitutionally vague, the court applied the wrong liability standard, and the injunction was overbroad and lacked specificity.
Court Holding & Legal Precedent
Issue: Does the term “imitation” in the Food, Drug, and Cosmetic Act encompass drugs that are merely “similar in concept” to controlled substances, and does an injunction enforcing the Act satisfy procedural rules if it fails to specify the prohibited acts?
Affirmed in part, reversed in part, and remanded. The court held that Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
IRAC Legal Analysis
Complete IRAC Analysis for Higher Grades
IRAC (Issue, Rule, Analysis, Conclusion) is the exact format professors want to see in your exam answers. Our exclusive Flash-to-Full briefs combine holding, analysis, and rule statements formatted to match what A+ students produce in exams. These structured briefs help reinforce the essential legal reasoning patterns expected in law school.
Legal Issue
Does the term “imitation” in the Food, Drug, and Cosmetic Act encompass drugs that are merely “similar in concept” to controlled substances, and does an injunction enforcing the Act satisfy procedural rules if it fails to specify the prohibited acts?
Conclusion
This case provides a controlling interpretation of "imitation" under the FDCA, limiting Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
Legal Rule
Under the Food, Drug, and Cosmetic Act, a drug is an "imitation" Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
Legal Analysis
The court's analysis focused on interpreting the scope of the FDA's regulatory Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
Flash-to-Full Case Opinions
Flash Summary
- The term “imitation” in the FDCA (21 U.S.C. § 352(i)(2)) is